Chapter 30: Adrenergic Agonists

Adrenergic Agonists focuses on Adrenergic Agonists, often referred to as sympathomimetic agents, which function by initiating or mimicking the effects of the sympathetic nervous system (SNS). These drugs achieve their action either through direct stimulation of adrenergic receptor sites or indirectly by modulating the release of neurotransmitters, such as norepinephrine. The therapeutic benefits derived from SNS stimulation include an increase in heart rate and myocardial contractility, bronchodilation leading to increased respiratory rate and depth, vasoconstriction that elevates blood pressure, dilation of pupils, and the metabolic process of glycogenolysis (the breakdown of stored glucose to increase blood sugar). The agents are broadly categorized into Alpha- and Beta-Adrenergic Agonists, Alpha-Specific Agonists, and Beta-Specific Agonists. Alpha- and Beta-Adrenergic Agonists, which include naturally occurring catecholamines like dopamine, epinephrine, and norepinephrine, are frequently employed for managing shock, hypotensive states, and asthma. Dopamine is highlighted as the agent of choice for shock treatment due to its unique ability to increase blood pressure while simultaneously promoting vasodilation in the renal and splanchnic beds, thus protecting kidney perfusion. Alpha-Specific Agonists, such as phenylephrine, are potent vasoconstrictors used in shock and as topical agents for rhinitis and eye dilation; newer drugs like midodrine and droxidopa are specifically approved for treating orthostatic hypotension. Clonidine, an alpha2-specific agonist, acts centrally to decrease sympathetic outflow and is used for hypertension. Beta-Specific Agonists, exemplified by isoproterenol, stimulate all beta-adrenergic receptors to increase cardiac rate and contractility and cause bronchodilation, making them effective for emergency situations like cardiac standstill. However, isoproterenol’s use is often limited due to toxicity and the risk of diverting blood away from injured cardiac areas (coronary steal effect). Key nursing considerations emphasize the necessity of precise dose calculations, especially for pediatric patients, and the crucial requirement for constant monitoring of vital signs, including blood pressure, pulse, and ECG, due to the high risk of cardiovascular adverse effects like arrhythmias and hypertension. A critical safety point involves preventing extravasation during intravenous administration, as the potent vasoconstriction can cause necrosis; infiltration with phentolamine should be readily available to counteract this effect. Patient education must cover the avoidance of abrupt drug discontinuation (which risks rebound hypertension), minimizing the intake of stimulants like caffeine, and being cautious with over-the-counter (OTC) cold and allergy medications and herbal supplements (such as ma huang), which can significantly increase sympathomimetic effects.